Alkemy Total Liab vs Accounts Payable Analysis

ALK Stock   130.00  7.50  5.45%   
Alkemy Capital financial indicator trend analysis is way more than just evaluating Alkemy Capital Inves prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Alkemy Capital Inves is a good investment. Please check the relationship between Alkemy Capital Total Liab and its Accounts Payable accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alkemy Capital Investments. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Total Liab vs Accounts Payable

Total Liab vs Accounts Payable Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Alkemy Capital Inves Total Liab account and Accounts Payable. At this time, the significance of the direction appears to have strong relationship.
The correlation between Alkemy Capital's Total Liab and Accounts Payable is 0.67. Overlapping area represents the amount of variation of Total Liab that can explain the historical movement of Accounts Payable in the same time period over historical financial statements of Alkemy Capital Investments, assuming nothing else is changed. The correlation between historical values of Alkemy Capital's Total Liab and Accounts Payable is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Liab of Alkemy Capital Investments are associated (or correlated) with its Accounts Payable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accounts Payable has no effect on the direction of Total Liab i.e., Alkemy Capital's Total Liab and Accounts Payable go up and down completely randomly.

Correlation Coefficient

0.67
Relationship DirectionPositive 
Relationship StrengthSignificant

Total Liab

The total amount of all liabilities that a company has, including both short-term and long-term liabilities.

Accounts Payable

An accounting item on the balance sheet that represents Alkemy Capital obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Alkemy Capital Inves are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.
Most indicators from Alkemy Capital's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Alkemy Capital Inves current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alkemy Capital Investments. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
The current year's Tax Provision is expected to grow to about (308.8 K). In addition to that, Selling General Administrative is expected to decline to about 805.3 K
 2010 2022 2023 2024 (projected)
Total Operating Expenses797.7K2.6M1.5M1.8M
Cost Of Revenue330.751.3K634.3K666.0K

Alkemy Capital fundamental ratios Correlations

0.810.98-0.991.0-0.940.77-1.0-1.00.720.28-0.060.920.98-0.370.990.950.98-0.58-0.80.77-0.54-0.8-0.580.540.57
0.810.88-0.880.83-0.590.26-0.78-0.780.190.7-0.610.670.880.170.860.60.69-0.04-0.340.42-0.11-0.36-0.040.110.04
0.980.88-1.00.99-0.880.67-0.98-0.980.610.41-0.230.851.0-0.31.00.890.92-0.43-0.740.75-0.47-0.75-0.430.470.42
-0.99-0.88-1.0-0.990.88-0.690.980.98-0.61-0.420.2-0.87-1.00.3-1.0-0.9-0.930.440.74-0.750.440.750.44-0.44-0.44
1.00.830.99-0.99-0.930.75-1.0-1.00.690.31-0.110.910.99-0.361.00.940.97-0.53-0.790.77-0.53-0.79-0.530.530.53
-0.94-0.59-0.880.88-0.93-0.880.960.96-0.90.06-0.21-0.95-0.880.52-0.9-0.98-0.980.80.87-0.740.770.860.8-0.77-0.8
0.770.260.67-0.690.75-0.88-0.79-0.790.96-0.210.560.770.67-0.810.70.920.86-0.85-0.960.85-0.67-0.95-0.850.670.85
-1.0-0.78-0.980.98-1.00.96-0.791.0-0.76-0.220.03-0.93-0.980.4-0.99-0.96-0.980.610.82-0.770.60.820.61-0.6-0.61
-1.0-0.78-0.980.98-1.00.96-0.791.0-0.76-0.220.03-0.93-0.980.4-0.99-0.96-0.980.610.82-0.770.60.820.61-0.6-0.61
0.720.190.61-0.610.69-0.90.96-0.76-0.76-0.420.60.790.61-0.760.640.890.83-0.94-0.910.73-0.84-0.88-0.940.840.94
0.280.70.41-0.420.310.06-0.21-0.22-0.22-0.42-0.780.020.410.370.380.030.10.580.110.150.570.060.58-0.57-0.58
-0.06-0.61-0.230.2-0.11-0.210.560.030.030.6-0.780.13-0.23-0.65-0.180.240.13-0.71-0.390.2-0.39-0.36-0.710.390.71
0.920.670.85-0.870.91-0.950.77-0.93-0.930.790.020.130.85-0.280.880.940.96-0.77-0.710.56-0.63-0.69-0.770.630.77
0.980.881.0-1.00.99-0.880.67-0.98-0.980.610.41-0.230.85-0.31.00.890.92-0.43-0.740.75-0.47-0.75-0.430.470.42
-0.370.17-0.30.3-0.360.52-0.810.40.4-0.760.37-0.65-0.28-0.3-0.32-0.56-0.450.60.85-0.820.580.850.6-0.58-0.6
0.990.861.0-1.01.0-0.90.7-0.99-0.990.640.38-0.180.881.0-0.320.910.94-0.47-0.760.76-0.49-0.77-0.470.490.47
0.950.60.89-0.90.94-0.980.92-0.96-0.960.890.030.240.940.89-0.560.910.99-0.77-0.90.81-0.65-0.89-0.770.650.77
0.980.690.92-0.930.97-0.980.86-0.98-0.980.830.10.130.960.92-0.450.940.99-0.73-0.850.76-0.63-0.84-0.730.630.73
-0.58-0.04-0.430.44-0.530.8-0.850.610.61-0.940.58-0.71-0.77-0.430.6-0.47-0.77-0.730.73-0.470.80.691.0-0.8-1.0
-0.8-0.34-0.740.74-0.790.87-0.960.820.82-0.910.11-0.39-0.71-0.740.85-0.76-0.9-0.850.73-0.950.711.00.73-0.71-0.73
0.770.420.75-0.750.77-0.740.85-0.77-0.770.730.150.20.560.75-0.820.760.810.76-0.47-0.95-0.49-0.96-0.470.490.47
-0.54-0.11-0.470.44-0.530.77-0.670.60.6-0.840.57-0.39-0.63-0.470.58-0.49-0.65-0.630.80.71-0.490.670.8-1.0-0.8
-0.8-0.36-0.750.75-0.790.86-0.950.820.82-0.880.06-0.36-0.69-0.750.85-0.77-0.89-0.840.691.0-0.960.670.69-0.67-0.69
-0.58-0.04-0.430.44-0.530.8-0.850.610.61-0.940.58-0.71-0.77-0.430.6-0.47-0.77-0.731.00.73-0.470.80.69-0.8-1.0
0.540.110.47-0.440.53-0.770.67-0.6-0.60.84-0.570.390.630.47-0.580.490.650.63-0.8-0.710.49-1.0-0.67-0.80.8
0.570.040.42-0.440.53-0.80.85-0.61-0.610.94-0.580.710.770.42-0.60.470.770.73-1.0-0.730.47-0.8-0.69-1.00.8
Click cells to compare fundamentals

Alkemy Capital Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Alkemy Stock

Balance Sheet is a snapshot of the financial position of Alkemy Capital Inves at a specified time, usually calculated after every quarter, six months, or one year. Alkemy Capital Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Alkemy Capital and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Alkemy currently owns. An asset can also be divided into two categories, current and non-current.